Meyka Pro banner
IM Cannabis Corp.

IM Cannabis Corp. Fundamental Analysis (CNQ: IMCC.CN)

IMCC.CN●CNQ
HealthcareDrug Manufacturers - Specialty & Generic
$5.10
$3.40(40.00%)
Canadian Market is Open · 12:58

IM Cannabis Corp. Fundamental Analysis (CNQ: IMCC.CN)

IM Cannabis Corp. (CNQ: IMCC.CN) shows weak financial fundamentals with a PE ratio of -1.13, profit margin of -19.59%, and ROE of -1.07%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.01

Areas of Concern

ROE-1.07%
Operating Margin-18.94%
Current Ratio0.67
We analyze IMCC.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -149.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-149.4/100

We analyze IMCC.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMCC.CN struggles to generate sufficient returns from assets.

ROA > 10%
-27.01%

Valuation Score

Excellent

IMCC.CN trades at attractive valuation levels.

PE < 25
-1.13
PEG Ratio < 2
-0.01

Growth Score

Weak

IMCC.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

IMCC.CN carries high financial risk with limited liquidity.

Debt/Equity < 1
3.44
Current Ratio > 1
0.67

Profitability Score

Weak

IMCC.CN struggles to sustain strong margins.

ROE > 15%
-107.40%
Net Margin ≥ 15%
-19.59%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMCC.CN Expensive or Cheap?

P/E Ratio

IMCC.CN trades at -1.13 times earnings. This suggests potential undervaluation.

-1.13

PEG Ratio

When adjusting for growth, IMCC.CN's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values IM Cannabis Corp. at 2.28 times its book value. This may indicate undervaluation.

2.28

EV/EBITDA

Enterprise value stands at -0.00 times EBITDA. This is generally considered low.

-0.00

How Well Does IMCC.CN Make Money?

Net Profit Margin

For every $100 in sales, IM Cannabis Corp. keeps $-19.59 as profit after all expenses.

-19.59%

Operating Margin

Core operations generate -18.94 in profit for every $100 in revenue, before interest and taxes.

-18.94%

ROE

Management delivers $-1.07 in profit for every $100 of shareholder equity.

-1.07%

ROA

IM Cannabis Corp. generates $-27.01 in profit for every $100 in assets, demonstrating efficient asset deployment.

-27.01%

Following the Money - Real Cash Generation

Operating Cash Flow

IM Cannabis Corp. generates limited operating cash flow of $-1.54M, signaling weaker underlying cash strength.

$-1.54M

Free Cash Flow

IM Cannabis Corp. generates weak or negative free cash flow of $-1.77M, restricting financial flexibility.

$-1.77M

FCF Per Share

Each share generates $-0.52 in free cash annually.

$-0.52

FCF Yield

IMCC.CN converts -7.18% of its market value into free cash.

-7.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.13

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.28

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.67

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.07

vs 25 benchmark

ROA

Return on assets percentage

-0.27

vs 25 benchmark

ROCE

Return on capital employed

-2.40

vs 25 benchmark

How IMCC.CN Stacks Against Its Sector Peers

MetricIMCC.CN ValueSector AveragePerformance
P/E Ratio-1.1331.35 Better (Cheaper)
ROE-107.40%547.00% Weak
Net Margin-19.59%9013.00% Weak
Debt/Equity3.440.51 Weak (High Leverage)
Current Ratio0.675.79 Weak Liquidity
ROA-27.01%3.00% Weak

IMCC.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IM Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ